Patent · US Active

Purification of recombinant EV71 virus-like particle and method for preparing vaccine thereof

US10987416B2 · kind B2 · utility

1Cited by
0References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 28, 2016
Grant dateApr 27, 2021
Priority date
Expiry dateDec 28, 2036

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2030/027
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a method for purifying an EV71 virus-like particle and a method for preparing a vaccine thereof. The virus-like particle is obtained by performing high density fermentation cultivation on recombinantly engineered bacteria; inducing expression of the EV71 virus-like particle protein expression using methanol; collecting the bacteria by centrifugation and performing high-pressure homogenization for disruption; performing precipitation on the supernatant with ammonium sulfate; and purifying by redissolution, ultrafiltration, ion exchange chromatography, molecular sieve chromatography, hydroxyapatite chromatography, etc.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.